Efficacy of Vancomycin and Meropenem in Central Nervous System Infections in Children and Adults: Current Update
The current antimicrobial therapy of bacterial infections of the central nervous system (CNS) in adults and pediatric patients is faced with many pitfalls as the drugs have to reach necessary levels in serum and cross the blood-brain barrier. Furthermore, several studies report that different factor...
Saved in:
Main Authors: | Franziska Schneider (Author), André Gessner (Author), Nahed El-Najjar (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systematic review of efficacy, safety and pharmacokinetics of intravenous and intraventricular vancomycin for central nervous system infections
by: Shu-Ping Liu, et al.
Published: (2022) -
Update on Viral Infections Involving the Central Nervous System in Pediatric Patients
by: Giovanni Autore, et al.
Published: (2021) -
Population Pharmacokinetics of Vancomycin and Meropenem in Pediatric Extracorporeal Membrane Oxygenation Support
by: Brenda Zylbersztajn, et al.
Published: (2021) -
Infections of the Central Nervous System
by: Mateusz Dobosz, et al.
Published: (2024) -
Comparison of the incidence of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or with meropenem
by: Majed S. Al Yami
Published: (2017)